CeriBell (NASDAQ:CBLL) CEO Xingjuan Chao Sells 39,540 Shares

CeriBell, Inc. (NASDAQ:CBLL) CEO Xingjuan Chao sold 39,540 shares of the firm’s stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $24.61, for a total transaction of $973,079.40. Following the completion of the sale, the chief executive officer owned 767,191 shares of the company’s stock, valued at $18,880,570.51. The trade was a 4.90% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.

Xingjuan Chao also recently made the following trade(s):

• On Friday, August 21st, Xingjuan Chao sold 6,068 shares of CeriBell stock. The shares were sold at an average price of $24.02, for a total value of $145,753.36.
• On Wednesday, August 19th, Xingjuan Chao sold 31,415 shares of CeriBell stock. The stock was sold at an average price of $25.03, for a total value of $786,317.45.
• On Tuesday, August 18th, Xingjuan Chao sold 2,199 shares of CeriBell stock. The shares were sold at an average price of $25.00, for a total value of $54,975.00.
• On Tuesday, July 7th, Xingjuan Chao sold 39,000 shares of CeriBell stock. The stock was sold at an average price of $19.90, for a total value of $776,100.00.
• On Monday, June 8th, Xingjuan Chao sold 39,000 shares of CeriBell stock. The shares were sold at an average price of $18.33, for a total transaction of $714,870.00.

CeriBell Stock Up 0.6%

CeriBell stock opened at $24.72 on Friday. The firm has a market capitalization of $948.75 million, a price-to-earnings ratio of -14.05 and a beta of 0.95. The firm’s fifty day moving average price is $20.67 and its two-hundred day moving average price is $19.49. CeriBell, Inc. has a 1-year low of $10.85 and a 1-year high of $25.33. The company has a current ratio of 9.18, a quick ratio of 8.79 and a debt-to-equity ratio of 0.16.

CeriBell (NASDAQ:CBLL) last posted its earnings results on Monday, August 10th. The company reported ($0.51) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.04). The business had revenue of $28.10 million during the quarter, compared to analyst estimates of $27.28 million. CeriBell had a negative return on equity of 44.85% and a negative net margin of 64.73%. On average, equities research analysts predict that CeriBell, Inc. will post -1.96 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on CBLL shares. Canaccord Genuity Group raised their price objective on CeriBell from $25.00 to $26.00 and gave the company a “buy” rating in a research note on Tuesday, August 11th. Raymond James Financial reissued a “strong-buy” rating and set a $29.00 price target on shares of CeriBell in a research report on Thursday. BTIG Research upped their price objective on shares of CeriBell from $28.00 to $30.00 and gave the stock a “buy” rating in a research report on Tuesday, August 18th. Weiss Ratings cut shares of CeriBell from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Friday, August 28th. Finally, Barclays raised CeriBell to a “neutral” rating in a research report on Tuesday, August 18th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $24.40.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CBLL. BlackRock Inc. purchased a new stake in shares of CeriBell during the 2nd quarter worth approximately $37,657,000. Vanguard Group Inc. increased its position in CeriBell by 11.1% in the third quarter. Vanguard Group Inc. now owns 1,473,856 shares of the company’s stock worth $16,935,000 after buying an additional 147,013 shares during the last quarter. KCM Capital Inc lifted its position in shares of CeriBell by 40.0% during the 1st quarter. KCM Capital Inc now owns 1,400,000 shares of the company’s stock valued at $25,662,000 after buying an additional 400,000 shares during the last quarter. Yu Fan grew its stake in shares of CeriBell by 10.7% during the 2nd quarter. Yu Fan now owns 1,353,166 shares of the company’s stock worth $25,345,000 after acquiring an additional 130,964 shares during the period. Finally, Bank of New York Mellon Corp increased its holdings in CeriBell by 1,945.9% in the 4th quarter. Bank of New York Mellon Corp now owns 1,221,927 shares of the company’s stock worth $26,797,000 after acquiring an additional 1,162,200 shares during the last quarter.

About CeriBell

CeriBell Corp (NASDAQ: CBLL) is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices. The company offers a suite of medical diagnostic tools based on otoacoustic emissions (OAE) and auditory brainstem response (ABR) technologies, enabling early detection of auditory impairments in infants. CeriBell’s solutions are used in hospitals, birthing centers and audiology clinics to support universal newborn hearing screening programs aimed at improving language development outcomes through prompt intervention.

The company’s product portfolio includes handheld and desktop screening units, proprietary software for data management, and accessories designed to streamline testing workflows.